Cholangiocarcinoma Clinical Trials in Philadelphia, Pennsylvania
7 recruitingPhiladelphia, Pennsylvania
Showing 1–7 of 7 trials
Recruiting
Phase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Breast NeoplasmsCholangiocarcinomaOvarian Neoplasms+4 more
Eli Lilly and Company241 enrolled28 locationsNCT07213791
Recruiting
Phase 1
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Ovarian CancerMesothelioma, MalignantCholangiocarcinoma Recurrent
Verismo Therapeutics42 enrolled4 locationsNCT05568680
Recruiting
Phase 1Phase 2
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
Cholangiocarcinoma
Genfit74 enrolled11 locationsNCT05874414
Recruiting
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
Liver CancerCholangiocarcinomaHepatocellular Carcinoma
National Cancer Institute (NCI)500 enrolled7 locationsNCT04145141
Recruiting
Phase 1
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Mesothelin-Expressing TumorsEpithelial Ovarian CancerLung Adenocarcinoma Metastatic+7 more
Context Therapeutics Inc.70 enrolled8 locationsNCT06756035
Recruiting
Phase 1Phase 2
A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors
CholangiocarcinomaAdvanced Solid TumorsIntrahepatic Cholangiocarcinoma (Icc)+9 more
Cogent Biosciences, Inc.110 enrolled15 locationsNCT06777316
Recruiting
Not Applicable
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
CholangiocarcinomaPancreatic Ductal AdenocarcinomaPancreatic Adenocarcinoma+5 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University845 enrolled2 locationsNCT02757859